ALPHAPTOSE GMBH has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are LONGEVERON LLC, KANISA PHARMACEUTICALS INC and ALPHARMA PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | Australia | 2 | |
#7 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special acyclic compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Weber Lutz | 19 |
#2 | Richter Wolfgang | 14 |
#3 | Khazak Vladimir | 5 |
#4 | Abramowski Pierre | 3 |
#5 | Martin Roland | 3 |
#6 | Diederichs Julia | 2 |
#7 | Ayuketang Francis Ayuk | 1 |
#8 | Zander Axel Rolf | 1 |
#9 | Lutz Weber | 1 |
#10 | Wolfgang Richter | 1 |
Publication | Filing date | Title |
---|---|---|
AU2014200509A1 | Methods and compositions for detecting receptor ligand mimetics | |
WO2013156630A1 | S-enantiomer of a tri-substituted glycerol compound | |
GB201208850D0 | Tri-subsituted glycerol compounds for use in the treatment of clinically isolated syndrome and/or multiple sclerosis | |
EP2120873A1 | Topical dosage form comprising tri-substituted glycerol compounds | |
CN101606061A | Methods and compositions for detecting receptor ligand mimetics | |
AU2007316588A1 | Oral dosage form comprising tri-substituted glycerol compounds | |
US2010130449A1 | Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries |